论文部分内容阅读
目的:调查对免疫增强药临床应用现状及合理性,为该类药物的合理使用提供参考。方法:利用医院HIS系统,随机抽取2012年在我院治疗的240例确诊为恶性肿瘤住院患者病历,调查免疫增强药的应用情况,评价临床应用免疫增强药的合理性。结果:不同年龄组及KPS评分组段,免疫增强药使用率的差异均无统计学意义(P>0.05)。214例患者使用了免疫增强药,使用率为89.2%,其中联合用药病历114份(47.5%);中药类免疫增强药用药金额占总金额的74.4%;不合理用药医嘱62份,占总病历数的25.8%,主要为溶媒使用不当。结论:我院免疫增强药使用情况总体良好,但也存在部分不合理现象,卫生行政部门及院相关管理部门应加强管理,促进该类药物的合理应用。
Objective: To investigate the status quo and rationality of clinical application of immune enhancement drugs and provide references for rational use of these drugs. Methods: The hospital HIS system was used to randomly select 240 cases of hospitalized patients diagnosed as malignant tumors in our hospital in 2012 to investigate the application of immune enhancing drugs and to evaluate the rationality of clinical application of immune enhancing drugs. Results: There were no significant differences in the usage rates of immunostimulants among different age groups and KPS scores (P> 0.05). The immunosuppressive drugs were used in 214 patients with a usage rate of 89.2%, of which 114 (47.5%) were combined medical records, 74.4% of the total amount of Chinese medicine immunostimulants, 62 were irrational medication instructions, The number of 25.8%, mainly for improper use of the solvent. Conclusion: The use of immunostimulants in our hospital is generally good, but there are also some unreasonable phenomena. The health administrative departments and relevant administrative departments of the hospital should strengthen management to promote the rational application of such drugs.